OPEN ACCESS JOURNALS

           

home

about us

journals

search

Journal of Medicinal Plants Research

     

   JMPR Home

   About JMPR

   Submit Manuscripts

   Instructions for Authors

   Editors

   Call For Paper

   Archive

   Faculty 1000

   Conferences

   Associations

 

J. Med. Plants Res.

 

  Vol. 5 No. 5
 

  Viewing options:
    • Abstract
    •
Reprint (PDF) (71K)

  Search Pubmed for

  articles by:
 

Jiangwei M

Xia X

 

 
  Other links:
  PubMed Citation
  Related articles in PubMed

 

 

Journal of Medicinal Plants Research Vol. 5(5), pp. 855858, 4 March, 2011

ISSN 1996-0875 ©2011 Academic Journals

 

 

Full Length Research Paper

 

Aqueous extract of Astragalus mongholicus ameliorates high cholesterol diet induced oxidative injury in experimental rats models

 

Ma Jiangwei, Qiao Zengyong* and Xiang Xia

 

Cardiology Department, Fengxian Branch of Shanghai 6th People’s Hospital, Shanghai, 201400, PR, China.

 

*Corresponding author. E-mail: qiaozydoctsh@sina.cn. Tel: +86 021 57412833. Fax: +86 021 57412833.

 

Accepted 12 January 2011

   

Abstract

 

Abstract

Introduction

Materials and Methods

Results and Discussion

References

 

 

 

Astragalus mongholicus is a Chinese traditional medicine. In this study, we sought to explore potential benefits in cardiovascular disorders associated with excess cholesterol and hyperlipidemia. We have investigated the effects of A. mongholicus extract as a dietary supplement on hyperlipidemia and oxidative stress in rats maintained on a high- cholesterol diet. Diets were supplemented with A. mongholicus extract at 0.4 and 0.8% for five weeks, while control animals received no supplement. A. mongholicus extract administration to hyperlipidemic rats resulted in a significant decline in serum levels of total cholesterol, triglycerides and low density lipoprotein-cholesterol, with an increase in serum high-density lipoprotein-cholesterol levels. Furthermore, A. mongholicus extract improved serum and heart antioxidant status as assessed by superoxide dismutase and glutathione peroxidase activities and reduced levels of lipid peroxidation. These results suggest that A. mongholicus extract consumption can improve lipid profiles, inhibit peroxidation, and increase the activity of antioxidant enzymes, and is thereby likely to reduce the risk of coronary heart disease associated with hyperlipidemia and oxidative stress.

 

Key words: Astragalus mongholicus extract, coronary heart disease, high- cholesterol diet.

 

 

 

Introduction

 

Abstract

Introduction

Materials and Methods

Results and Discussion

References

 

 

Astragalus is a perennial legume plant; its root has been of medicinal use for centuries within the traditional Chinese system. Astragalus mongholicus and Astragalus membranaceus are the two species most often prescribed, for general debility, chronic illnesses, and increase of the overall vitality of patients. The main ingredients of A. membranaceus var. mongholicus (synonym A. mongholicus, AM) are polysaccharides (Kitagawa et al., 1983a), saponins, and flavonoids (Kitagawa et al., 1983b; Kitagawa et al., 1983c; Aldarmaa et al., 2010). In traditional medicine, AM has been used for the treatment of general weakness, chronic illness, and to increase overall vitality. Different peripheral effectssuch  as  improved sensitivity to insulin (Lin et al., 2000), immune modulation, antiviral activity, antineoplastic activity, and enhancement of cardiovascular functions have been described (Monograph, 2003). The protection of cardiovascular function might be explained in terms of protection against membrane lipid peroxidation (Chen et al., 1995; Wang et al., 1996; Toda and Shirataki, 1999; Shuai et al, 2010).

   Oxidative stress is currently suggested as a mechanism underlying hypercholesterolemia. Free radicals are continually produced in the body as the result of normal metabolic processes and interaction with environmental stimuli. Enzymatic antioxidant defenses include superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), and catalase (CAT). Nonenzymatic antioxidants are represented by ascorbic acid (vitamin C), α-tocopherol (vitamin E), glutathione (GSH), carotenoids, flavonoids, and other antioxidants. Under normal conditions, there is a balance between both the activities and  the  intracellular  levels  of  these  antioxidants.  This balance is essential for the survival of organisms and their health (Valko et al., 2007; BeMiller, 2011; Shiga, Cordenunsi and Lajolo, 2009). Oxidative stress results from imbalance between radical-generating and radical-scavenging systems, that is, increased free radical production or reduced activity of antioxidant defenses or the both.

Hypercholesterolemia, high-cholesterol diet, and oxidative stress increase serum total cholesterol (TC) and low-density lipoprotein (LDL) cholesterol levels, resulting in increased risk for atherosclerosis development (Hakimoglu et al., 2007). In such conditions, antioxidants play an important role in inhibiting and scavenging radicals, thus, providing protection to humans against infectious and degenerative diseases. In the present experiment, we examined effect of A. mongholicus extract on oxidative injury in rats fed with a high- cholesterol diet.

 

 

 

                                                              Table 1. Effect of A. mongholicus extract on serum MDA level.

 

Group

MDA (μmol/ml)

NC

6.38 ± 0.32

UMC

12.54 ± 0.84$$

AME (0.4%)

9.12 ± 0.47##

AME (0.8%)

7.26 ± 0.43##

 

                                                             $$p < 0.01, vs NC group; ##p < 0.01, vs UMC group, NC: normal control;

                                                             UMC: untreated model control; AME: A. mongholicus extract.

 

 

   

Materials and Methods

 

Abstract

Introduction

Materials and Methods

Results and Discussion

References

 

 

Plant material and extraction

 

A. mongholicus used in this study were purchased in a local market. Plant materials were extracted in boiling water for 2 h. After 2 h of extraction, the procedure was repeated. After centrifugation, the combined extract was evaporated in a rotary evaporator and freeze-dried.

 

 

Animals and dietary treatment

 

Twelve male Wistar rats weighing 178 ± 10 g were housed in stainless steel cages in a room with controlled lighting (12 h light:dark cycle), constant temperature (24°C) and relative humidity (60%).

The animals were randomly divided into four groups of six rats each and fed a different diet for 5 weeks, as follows: one group (normal control) fed a standard diet; one group (model control) fed a diet containing 1% cholesterol and 0.5% cholic acid, that is, high cholesterol diet (HCD) and the other two groups (AME-treatment) fed the HCD diet supplemented with 0.4 and 0.8% A. mongholicus extract, respectively. After 5 weeks of treatment, the animals were fasted overnight and then sacrificed under diethyl ether anesthesia. All experiments were carried out according to the guidelines for the care and use of experimental animals and approved by state veterinary  administration  of China. Blood and heart tissue samples were taken from the animals of all groups. The heart tissue was immediately washed with saline, blotted on filter paper, weighted and then cut into small pieces and homogenized in Tris–HCl buffer (0.025 M, pH 7.5) with a homogenizer to give a 10% (w/v) heart homogenate. The homogenate was then centrifuged at 12,000 rpm for 15 min and the supernatant obtained was frozen until use. Serums were separated from the blood samples and were stored at −70°C pending biochemical analyses.

 

 

Biochemical analysis

 

Blood malondialdehyde (MDA) level was estimated according to method of Draper and Hadley (1990), which is based on the coupling MDA with thiobarbituric acid. Triglycerides (TG), TC, HDL-c and LDL-c in serum were determined with enzymatic kits. The activities of SOD (Sun et al., 1988), CAT (Aebi, 1974) and GPx were measured in blood and heart tissue homogenates. Tissue protein content was assayed by colorimetric method of Lowry et al. (1951).

 

 

Statistical analyses

 

Data were analyzed using Student's t-test and p < 0.05 was considered significant. Values are expressed as means ± standard deviation (S.D.) for six rats per group.

 

   

Results and Discussion

 

Abstract

Introduction

Materials and Methods

Results and Discussion

References

 

Oxidative stress and lipid peroxidation have been implicated in atherogenesis. One of the byproducts of lipid peroxidation is MDA. Modification of proteins with MDA changes antigenicity, function, and turnover kinetics of various proteins and has been implicated as a pathogenetic mechanism of atherosclerosis (Haberland et al., 1988; Mooradian et al., 1995, 1996; Lung et al., 1993; Shah et al., 1994).

As shown in Table 1, the untreated model control group exhibited significantly higher concentrations of serum MDA than normal control group, whereas HCD supplemented with 0.4 and 0.8% A. mongholicus extract groups displayed significantly lower concentrations of serum MDA than the untreated model control group.

The association of serum TC and low-density lipoprotein cholesterol (LDL-c) with developing coronary heart disease (CHD) has been well established, and low serum high-density lipoprotein cholesterol (HDL-c) is considered a major risk factor for CHD. There are some evidences that serum TG may be an independent risk factor for cardiovascular diseases (CVD) (Hokanson and Austin, 1996). Elevated TG and low HDL-c are basic characteristics of insulin resistance and the metabolic syndrome (MetS), which are strongly associated with CHD (McLaughlin et al., 2003). TG/HDL-c ratio, as a relatively novel lipoprotein index, indicates the presence of small dense LDL particles and could serve as a good predictor of CHD (Barzi et al., 2005; Gaziano et al., 1997). In the present study, serum TC, TG and LDL-c concentrations  were  markedly higher in untreated model

 

 

 

 

                Table 2. Effect of A. mongholicus extract on serum TC, TG, LDL-c and HDL-c levels.

 

Group

TC (mmol/ml)

TG (mmol/ml)

LDL-c (mmol/ml)

HDL-c (mmol/ml)

NC

3.28 ± 0.11

2.01 ± 0.14

0.94 ± 0.05

1.93 ± 0.09

UMC

5.27 ± 0.21 $$

3.92 ± 0.12 $$

1.73 ± 0.09 $$

0.94 ± 0.05 $$

AME (0.4%)

4.05 ± 0.19 ##

3.15 ± 0.17 ##

1.48 ± 0.08 ##

1.48 ± 0.08 ##

AME (0.8%)

3.17 ± 0.13 ##

2.27 ± 0.12 ##

1.02 ± 0.06 ##

1.87 ± 0.09 ##

 

               $$p < 0.01, vs NC group; ##p < 0.01, vs UMC group, NC: normal control; UMC: untreated model control; AME: A. mongholicus extract.

 

 

 

                        Table 3. Effect of A. mongholicus extract on serum SOD, CAT and GPx activities.

 

Group

SOD (U/ml)

CAT (U/ml)

GPx (U/ml)

NC

98.43 ± 3.76

21.65 ± 2.04

18.59 ± 1.28

UMC

56.21 ± 2.64$$

12.57 ± 1.11$$

11.09 ± 0.94$$

AME (0.4%)

70.84 ± 4.02##

17.05 ± 1.53##

15.37 ± 1.33##

AME (0.8%)

87.43 ± 5.38##

20.51 ± 1.59##

18.68 ± 1.57##

 

                       $$p < 0.01, vs NC group; ##p < 0.01, vs UMC group, NC: normal control; UMC: untreated model control; AME: A. mongholicus extract.

 

 

 

                   Table 4. Effect of A. mongholicus extract on heart SOD, CAT and GPx activities.

 

Group

SOD (U/mg)

CAT (U/mg)

GPx (U/mg)

NC

121.36 ± 10.37

27.04 ± 1.42

20.16 ± 1.42

UMC

77.39 ± 5.38$$

14.63 ± 1.74$$

14.29 ± 1.19$$

AME (0.4%)

97.38 ± 4.02##

20.82 ± 1.88##

17.99 ± 1.35##

AME (0.8%)

117.32 ± 9.47##

26.37 ± 2.05##

21.27 ± 1.71##

 

                    $$p < 0.01, vs NC group; ##p < 0.01, vs UMC group, NC: normal control; UMC: untreated model control; AME: A. mongholicus
                   
extract.

 

 

 

control groups compared with the normal control group. In contrast, serum HDL-c concentration was markedly lower in untreated model control groups compared with the normal control group. Supplementation of the drinking water of the HCD rats with A. mongholicus extract significantly decreased serum TC, TG and LDL-c concentrations relative to that of the untreated HCD group (p < 0.05, Table 2).

There is an ongoing debate as to whether soy dietary supplements are of therapeutic use against a variety of cardiovascular diseases in humans (Anderson et al., 1995; Clarkson, 2002; Sacks et al., 2006). In a number of rat models, however, improvements in several cardiovascular risk factors are striking (Mahn et al., 2005; Park et al., 2005; Trujillo et al., 2005; Douglas et al., 2006).

In recent years, antioxidants have gained a lot of importance because of their potential as prophylactic and therapeutic agents in many diseases. Human antioxidant defense is equipped with enzymatic scavengers like superoxide   dismutase   (SOD),   catalase     (CAT)    and glutathione peroxidase; hydrophilic scavengers like urate, ascorbate, glutathione and flavonoids; lipophilic radical scavengers such as tocopherols, carotenoids and ubiquinol (Pan and Mei, 2010; Alim et al., 2009; Abdelhalim, 2010). The defense also comprises enzymes involved in the reduction of oxidized forms of molecular antioxidants like glutathione reductase, dehydroascorbate reductase. Apart from these scavengers, there exists cellular machinery, which maintains a reducing environment, for example regeneration of NADPH by glucose-6-phosphate dehydrogenase (Sefi et al., 2010). Some of these agents synthesized by cell itself; however, majority including ascorbic acid, lipoic acid, polyphenols and carotenoids are derived from dietary sources. In disease conditions, the defense against ROS is weakened or damaged and the oxidant load increases. In such conditions, external supply of antioxidants is essential to countervail the deleterious consequences of oxidative stress (Rocha et al., 2009).

As shown in Tables 3 and 4, the untreated model control  group  significantly  reduced  the activities of CAT, SOD and GPx when compared to the normal control group. The results showed that HCD supplemented with 0.4 and 0.8% A. mongholicus extract significantly increased serum and heart CAT, SOD and GPx activities when compared to the untreated model control group.

   

References

 

Abstract

Introduction

Materials and Methods

Results and Discussion

References

 

 

Abdelhalim MAK (2010).The changes of iron and zinc concentrations in heart and aortic tissues of rabbits fed on high fat diet during the progression of atherosclerosis. Afr. J. Microbio. Res., 4(15): 1670-1675.

 

Aebi H (1974). Catalase in vitro. In: U. Bergmeyer, Editor, Methods of Enzymatic Analysis, Academic Press, New York/London, 667-673.

 

Aldarmaa J, Liu Z, Long J, Mo X, Ma J, Liu J (2010). Anti-convulsant effect and mechanism of Astragalus mongholicus extract in vitro and in vivo: protection against oxidative damage and mitochondrial dysfunction, Neurochem. Res., 35: 33–41.

 

Alim A, Goze I, Cetin A, Atas AD, Cetinus SA, Vural N (2009). Chemical composition and in vitro antimicrobial and antioxidant activities of the essential oil of Nepeta nuda L. subsp. Albiflora (Boiss.) gams. Afr. J. Microbiol. Res., 3(8): 463-467.

 

Anderson JW, Johnstone BM, Cook-Newell ME (1995). Meta-analysis of the effects of soy protein intake on serum lipids, N. Engl. J. Med., 333: 276-282.

 

Barzi F, Patel A, Woodward M, Lawes CM, Ohkubo T, Gu D, Lam TH, Ueshima H (2005). A comparison of lipid variables as predictors of cardiovascular disease in the Asia Pacific region, Ann. Epidemiol., 15: 405-413.

 

BeMiller JN (2011). Contributions of Roy L. Whistler to carbohydrate polymer science.  Carbohydrate Polymers, 83: 2022-2026.

 

Chen LX, Liao JZ, Guo WQ (1995). Effects of Astragalus membranaceus on left ventricular function and oxygen free radical in acute myocardial infarction patients and mechanisms of its cardiotonic action, Zhongguo Zhong Xi Yi Jie He Ha Zhi, 15: 141-143.

 

Clarkson TB (2002). Soy, soy phytoestrogens and cardiovascular disease, J. Nutr., 132: 566S-569S.

 

Douglas G, Armitage JA, Taylor PD, Lawson JR, Mann GE (2006). Poston, L. Cardiovascular consequences of life long exposure to dietary isoflavones in the rat, J. Physiol., 571: 477-487.

 

Draper HH, Hadley M (1990). Malondialdehyde determination as index of lipid peroxidation, Methods Enzymol., 186: 421-431.

 

Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE (1997) Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction, Circ., 96: 2520-2525.

 

Haberland ME, Fong D, Cheng L (1988), Malondialdehyde altered protein occurs in atheroma of Watanabe hyperlipidemic rabbits. Sci., 241: 215.

 

Hakimoglu F, Kizil G, Kanay Z, Kizil M, Iisi H (2007). The effect of ethanol extract of Hypericum lysimachioides on lipid profile in hypercholesterolemic rabbits and its in vitro antioxidant activity, Atherosclerosis, 192: 113-122.

 

Hokanson JE, Austin MA.. (1996). Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies, J. Cardiovasc. Risk, 3: 213-219.

 

Kitagawa I, Wang HK, Saponin MS, Sapogenol XXXV (1983a). Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge, (2). Astragalosides I, II, and IV, acetylastragaloside I and isoastragalosides I and II, Chem. Pharmaceut. Bull., 31: 698-708.

 

Kitagawa I, Wang HK, Saponin TA, Sapogenol XXXIV (1983b). Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (1) Cycloastragenol, the 9,19-cyclolanostane-type aglycone of astragalosides, artifact aglycone astragenol, Chem. Pharmaceut. Bull., 31: 689-697.

 

Kitagawa I, Wang HK, Saponin YM, Sapogenol XXXVII (1983c). Chemical constituents of Astragali Radix, the root of Astragalus membranaceus Bunge. (4) Astragalosides VII and VIII, Chem. Pharmaceut. Bull., 31: 716-722.

 

Lin LZ, He XG, Lindenmaier M, Nolan G, Yang J, Cleary M, Qiu SX, Cordell GA (2000). Liquid chromatography–electrospray ionization mass spectrometry study of the flavonoids of the roots of Astragalus mongholicus and A. membranaceus, J. Chromatogr.  A., 876: 87-95.

 

Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193: 265-275.

 

Lung CC, Pinnas JL, Yahya MD, Meinke GC, Mooradian AD (1993), Malondialdehyde modified proteins and their antibodies in the plasma of control and streptozotocin-induced diabetic rats. Life Sci., 52: 329.

 

Mahn K, Borras C, Knock GA, Taylor P, Khan IY, Sugden D, Poston L, Ward JP, Sharpe RM, Vina J, Aaronson PI, Mann GE (2005). Dietary soy isoflavone induced increases in antioxidant and eNOS gene expression lead to improved endothelial function and reduced blood pressure in vivo, FASEB J., 19: 1755-1757.

 

McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G (2003). Use of metabolic markers to identify overweight individuals who are insulin resistant, Ann. Intern. Med., 139: 802-809.

 

Monograph (2003). Astragalus membranaceus, Altern. Med. Rev., 8: 72-77.

 

Mooradian AD, Lung CC, Pinnas JL(1996), Glycosylation enhances malondialdehyde binding to proteins. Free Rad. Biol. Med., 21: 699.

 

Mooradian AD, Lung CC, Pinnas JL (1995), Cholesterol enriched diet enhances malondialdehyde modification of proteins in cerebral microvessels of rabbits. Neurosci. Lett., 185: 211.

 

Pan DD, Mei XM (2010). Antioxidant activity of an exopolysaccharide purified from Lactococcus lactis subsp. lactis 12. Carbohyd. Polym., 80: 908-914.

 

Park E, Shin JI, Park OJ, Kang MH (2005). Soy isoflavone supplementation alleviates oxidative stress and improves systolic blood pressure in male spontaneously hypertensive rats, J. Nutr. Sci. Vitaminol., (Tokyo) 51: 254-259.

 

Rocha KKR, Souza GA, Ebaid GX, Seiva FRF, Cataneo AC, Novelli ELB (2009). Resveratrol toxicity: Effects on risk factors for atherosclerosis and hepatic oxidative stress in standard and high-fat diets. Food Chem. Toxicol., 47: 1362-1367.

 

Sacks FM, Lichtenstein A, Van HL, Harris W, Kris-Etherton P, Winston M (2006). Soy protein, isoflavones, and cardiovascular health. An American heart association science advisory for professionals from the nutrition committee, Circ., 113: 1034-1044.

 

Sefi M, Fetoui H, Makni M, Zeghal N (2010). Mitigating effects of antioxidant properties of Artemisia campestris leaf extract on hyperlipidemia, advanced glycation end products and oxidative stress in alloxan-induced diabetic rats. Food Chem. Toxicol., 48: 1986-1993.

 

Shah G, Pinnas JL, Lung CC, Mahmoud S, Mooradian AD (1994) Tissue specific distribution of malondialdehyde modified proteins in diabetes mellitus. Life Sci., 55: 1343.

 

Shiga TM, Cordenunsi BR, Lajolo FM. (2009).  Effect of cooking on non-starch polysaccharides of hard-to-cook beans. Carbohydr. Polymers., 76: 100-109.

 

Shuai XH, Hu TJ, Liu HL, Su ZJ, Zeng Y, Li YH (2010). Immunomodulatory effect of a Sophora subprosrate polysaccharide in mice. Int. J. Biol. Macromol., 46: 79-84.

 

Sun Y, Oberley LW, Li Y (1988). A simple method for clinical assay of superoxide dismutase, Clin. Chem., 34: 497-500.

Toda S, Shirataki Y (1999). Inhibitory effects of Astragali radix, a crude drug in oriental medicines, on lipid peroxidation and protein oxidative modifications by copper, J. Ethnopharmacol., 68: 331-333.

 

Trujillo J, Ramirez V, Perez J, Torre-Villalvazo I, Torres N, Tovar AR, Munoz RM, Uribe N, Gamba G, Bobadilla NA (2005). Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation, Am. J. Physiol. Renal Physiol., 288: F108-F116.

 

Valko M, Leibfritz D, Moncol J, Cronin V, Mazur M, Telser J (2007). Free radicals and antioxidants in normal physiological functions and human disease, Int. J. Biochem. Cell. Biol., 39: 44-84.

 

Wang D, Shen W, Tian Y, Sun Z, Jiang C, Yuan S (1996). Protective effect of active components extracted from radix Astragali on human erythrocyte membrane damages caused by reactive oxygen species, Zhongguo Zhong Yao Za Zhi, 21: 746-748.

 

___________________________________________________________________________________________________________

Advertise on JMPR | Terms of Use | Privacy Policy | Help

© Academic Journals 2002 - 2011